Tyverb (lapatinib) - Important Safety Information from Novartis Ireland Ltd. as approved by HPRA

Notice type: 3rd Party Publications

Date: 22/05/2019

 

Problem Or Issue:

Tyverb (lapatinib): Important update to Summary of Product Characteristics from Novartis Ireland Ltd.

 

Important Safety Information - Tyverb (lapatinib)




« Back